Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population - implications for association study design and clinical genetic testing services
dc.contributor.author | Dissanayake, V.H.W. | |
dc.contributor.author | Weerasekera, L.Y. | |
dc.contributor.author | Gammulla, C.G. | |
dc.contributor.author | Jayasekara, R.W. | |
dc.date.accessioned | 2015-05-19T09:25:45Z | |
dc.date.available | 2015-05-19T09:25:45Z | |
dc.date.issued | 2009 | |
dc.identifier.citation | Experimental and Molecular Pathology, 87(2):p.159-162 | |
dc.identifier.reportnumber | FR 1485 | |
dc.identifier.researchgrantnumber | SIDA/2004/BT/001 | |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/19399 | |
dc.subject | Medical Sciences | |
dc.subject | Methylenetetrahydrofolate reductase | |
dc.subject | Factor V | |
dc.subject | Factor II | |
dc.subject | Population genetics | |
dc.title | Prevalence of genetic thrombophilic polymorphisms in the Sri Lankan population - implications for association study design and clinical genetic testing services | |
dc.type | Article |